Therefore, we are now working to verify the gene signatures of C1QC+ and SPP1+ TAMs in the clinical specimens of patients with cervical cancer at different clinical stages by utilizing single-cell sequencing technology. The gene discussed is SPP1; the disease is cervical carcinoma.